| Title | Therapeutics and Clinical Risk Management |
| Abbreviation | Ther. Clin. Risk Manag. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Safety Research (Q1); Chemical Health and Safety (Q2); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2) |
| h-index | 74 |
| Overall Rank/Ranking | 8124 |
| SCImago Journal Rank (SJR) | 0.699 |
| Impact Score | 2.48 |
| Publisher | Dove Medical Press Ltd |
| Country | New Zealand |
| ISSN | 11766336, 1178203X |
| Best Quartile | Q1 |
| Coverage History | 2006-2025 |
An international, peer-reviewed journal of clinical therapeutics and risk management, focusing on concise rapid reporting of clinical studies in all therapeutic areas, outcomes, safety, and programs for the effective, safe, and sustained use of medicines.
Therapeutics and Clinical Risk Management is a journal covering the technologies/fields/categories related to Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Safety Research (Q1); Chemical Health and Safety (Q2); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2). It is published by Dove Medical Press Ltd. The overall rank of Therapeutics and Clinical Risk Management is 8124. According to SCImago Journal Rank (SJR), this journal is ranked 0.699. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 74. The best quartile for this journal is Q1.
The ISSN of Therapeutics and Clinical Risk Management journal is 11766336, 1178203X. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Therapeutics and Clinical Risk Management is cited by a total of 855 articles during the last 3 years (Preceding 2024).
The Impact IF 2024 of Therapeutics and Clinical Risk Management is 2.48, which is computed in 2025 as per its definition. Therapeutics and Clinical Risk Management IF is increased by a factor of 0.13 and approximate percentage change is 5.53% when compared to preceding year 2023, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2024 of Therapeutics and Clinical Risk Management is 2.48. If the same upward trend persists, Impact IF may rise in 2025 as well.
| Year | Impact IF |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 2.48 |
| 2023 | 2.35 |
| 2022 | 2.90 |
| 2021 | 2.61 |
| 2020 | 2.30 |
| 2019 | 2.03 |
| 2018 | 1.90 |
| 2017 | 2.18 |
| 2016 | 2.54 |
| 2015 | 2.42 |
| 2014 | 2.02 |
Therapeutics and Clinical Risk Management has an h-index of 74. It means 74 articles of this journal have more than 74 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Therapeutics and Clinical Risk Management is 11766336, 1178203X. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Therapeutics and Clinical Risk Management is 8124. According to SCImago Journal Rank (SJR), this journal is ranked 0.699. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 0.699 |
| 2023 | 0.752 |
| 2022 | 0.652 |
| 2021 | 0.598 |
| 2020 | 0.719 |
| 2019 | 0.604 |
| 2018 | 0.725 |
| 2017 | 0.748 |
| 2016 | 0.765 |
| 2015 | 0.706 |
| 2014 | 0.619 |
| Year | Ranking |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 8124 |
| 2023 | 6816 |
| 2022 | 7795 |
| 2021 | 8294 |
| 2020 | 6913 |
| 2019 | 8202 |
| 2018 | 6608 |
| 2017 | 6285 |
| 2016 | 6116 |
| 2015 | 6744 |
| 2014 | 7497 |
Therapeutics and Clinical Risk Management is published by Dove Medical Press Ltd. It's publishing house is located in New Zealand. Coverage history of this journal is as following: 2006-2025. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Therapeutics and Clinical Risk Management is Ther. Clin. Risk Manag.. This abbreviation ('Ther. Clin. Risk Manag.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Safety Research (Q1); Chemical Health and Safety (Q2); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Therapeutics and Clinical Risk Management latest impact IF is 2.48. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 2.90 (2022) and 1.90 (2018), respectively, in the last 11 years. Moreover, its average IS is 2.34 in the previous 11 years.
The Therapeutics and Clinical Risk Management has an SJR (SCImago Journal Rank) of 0.699, according to the latest data. It is computed in the year 2025. In the past 11 years, this journal has recorded a range of SJR, with the highest being 0.765 in 2016 and the lowest being 0.598 in 2021. Furthermore, the average SJR of the Therapeutics and Clinical Risk Management over the previous 11-year period stands at 2.34.
The latest h-index of the Therapeutics and Clinical Risk Management is 74.
The Therapeutics and Clinical Risk Management is published by the Dove Medical Press Ltd, with its country of publication being the New Zealand.
The Therapeutics and Clinical Risk Management is currently ranked 8124 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 11 years, this journal has experienced varying rankings, reaching its highest position of 6116 in 2016 and its lowest position of 8294 in 2021.
The standard ISO4 abbreviation for the Therapeutics and Clinical Risk Management is Ther. Clin. Risk Manag..
Therapeutics and Clinical Risk Management is classified as a journal that the Dove Medical Press Ltd publishes.
The Therapeutics and Clinical Risk Management encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Therapeutics and Clinical Risk Management is assigned the following International Standard Serial Numbers (ISSN): 11766336, 1178203X.
The best quartile for the Therapeutics and Clinical Risk Management is Q1 (2024).
The Therapeutics and Clinical Risk Management coverage history can be summarized as follows: 2006-2025.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Journal of Academic Ethics | journal | 8704 | Springer Netherlands | 34 | 4.04 |
| SPE Production and Operations Symposium, Proceedings | conference and proceedings | 15907 | 21 | 0.00 | |
| Clinical Medicine and Research | journal | 14921 | Marshfield Clinic | 64 | 1.25 |
| Air and Space Power Journal (discontinued) | journal | 28397 | AU Press | 9 | 0.20 |
| Abacus | journal | 11890 | Wiley-Blackwell Publishing Ltd | 56 | 2.95 |
| Transnational Corporations | journal | 13970 | UNCTAD United Nations Conference on Trade and Development | 30 | 1.63 |
| Educational Measurement: Issues and Practice | journal | 6760 | Wiley-Blackwell Publishing Ltd | 68 | 1.54 |
| Libyan Studies | journal | 21508 | Cambridge University Press | 10 | 0.14 |
| Statistica | journal | 18529 | University of Bologna | 9 | 0.38 |
| Cuadernos de historia (Santiago, Chile) | journal | 20049 | Universidad de Chile, Facultad de Filosofia y Humanidades, Departamento de Literatura | 6 | 0.41 |
| Year | Impact Score (IS) |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 2.48 |
| 2023 | 2.35 |
| 2022 | 2.90 |
| 2021 | 2.61 |
| 2020 | 2.30 |
| 2019 | 2.03 |
| 2018 | 1.90 |
| 2017 | 2.18 |
| 2016 | 2.54 |
| 2015 | 2.42 |
| 2014 | 2.02 |